SCHEMBL5888532

SCHEMBL5888532

C[C@H](NC(=O)c1cncc(Br)c1)c1cccc(-c2cccnc2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.50
▸ CSF1R P07333 2/20 0.48
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ CASP3 P42574 2/20 0.46
▸ ROCK1 Q13464 8/20 0.45
▸ PRKACA P17612 3/20 0.45
▸ GSK3A P49840 3/20 0.45
▸ GSK3B P49841 3/20 0.45
▸ PRKX P51817 3/20 0.45
▸ PRKCQ Q04759 2/20 0.45
▸ MST1R Q04912 1/20 0.45
▸ ROCK2 O75116 6/20 0.45
▸ PRKG1 Q13976 3/20 0.45
▸ MAPK1 P28482 3/20 0.45
▸ CYP3A4 P08684 3/20 0.45
▸ CHEK1 O14757 2/20 0.45
▸ RPS6KA5 O75582 2/20 0.45
▸ PRKCG P05129 2/20 0.45
▸ CDK1 P06493 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5888537 1.00 ALDH1A1 (0.50) ALDH1A1CSF1RMEN1KMT2ACASP3
SCHEMBL5214941 0.85 ROCK2 (0.57) ALDH1A1CSF1RROCK1PRKACAGSK3A
SCHEMBL5224427 0.85 ROCK2 (0.57) ALDH1A1CSF1RROCK1PRKACAGSK3A
SCHEMBL12191029 0.82 ROCK2 (0.57) ALDH1A1CSF1RMEN1KMT2AROCK1
SCHEMBL12191087 0.82 ROCK2 (0.57) ALDH1A1CSF1RMEN1KMT2AROCK1
SCHEMBL12191128 0.77 GPR55 (0.53) ALDH1A1MEN1KMT2AROCK1ROCK2
SCHEMBL5888493 0.76 CTSL (0.49) ALDH1A1CYP3A4CYP2C9DYRK1ACTSL
SCHEMBL5888653 0.76 CTSL (0.52) ALDH1A1MEN1DYRK1ACTSLCTSS
SCHEMBL5888650 0.76 CTSL (0.52) ALDH1A1MEN1DYRK1ACTSLCTSS
SCHEMBL5888488 0.76 CTSL (0.49) ALDH1A1CYP3A4CYP2C9DYRK1ACTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7135472-B2 3-Heterocyclic benzylamide derivatives as potassium channel openers BRISTOL-MYERS SQUIBB COMPANY (US) 2006-11-14 — — US disclosed
Send feedback